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multiple longitudinal studies now ongoing are acquiring
serial images of joints to track the structural progress of dis-
ease. When reading or analysing serial images using any
method in which human judgment plays a part (as opposed
to fully automated or computerized methods) it is generally
accepted that viewing a subject’s images from different
timepoints grouped together reduces measurement error
by enabling the readers to re-evaluate and adjust measure-
ments made on these images, taking into account variation
in ﬁlm quality, positioning and other factors1,2.
However, a major question that still arises is whether the
grouped images from a person should be evaluated in known
chronological order or whether the images ought to be pre-
sented with the analyst or reader blinded to the sequence
in which they were acquired (the order of ﬁlms is not re-
vealed). (For the purposes of this editorial, we shall call the
ﬁrst approach ‘known chronology’ and the second ‘blinded
to sequence’.) The former scenario is similar to a clinical
reading where a clinician or radiologist knows the sequence
and tries to determine whether a patient has experienced
a change in disease status. The latter procedure is one
that has been instituted for some3,4, but not all5,6, clinical
trials in osteoarthritis. Blinding to sequence is said to be
conservative and rigorous and has been adopted by the
osteoarthritis initiative in initial analyses of both radiographic
and magnetic resonance images (MRI’s).
The main rationale behind blinding to sequence is to
reduce reader bias toward ﬁnding change in the expected
direction and secondarily to minimize bias by readers who
might be privy to information about risk factor status or treat-
ment received. As noted above, these issues are relevant
for any measurements from grouped serial images in which
human judgment plays a role in determining the result,
whether qualitative, semi-quantitative or quantitative. Even
operations like segmentation of MRI images and digital
measurements of joint space often have a manual compo-
nent that can be inﬂuenced by whether the images are
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281potential for bias depends on which aspects of a method
can be inﬂuenced by human judgment and to what extent.
The FDA has no formal policy on whether images from
trials should be read blinded to sequence or with known
chronology. In angiography studies as one example where
serial images are used to measure the primary outcomes
(luminal narrowing), images are analyzed in a manual or
semi-automated fashion with known chronology. In a recent
policy paper on best practices in Medical Imaging Tech-
niques for trials7, the FDA and PhRMA worked together to
identify multiple different acceptable scenarios for image
presentation including blinded to sequence or known chro-
nology displays. As is noted, ‘‘the type of presentation often
depends on the therapeutic area, the imaging technology
being deployed, and the reasons for the review’’ of images.
Given this uncertainty, we sought evidence on the perfor-
mance of blinding to sequence vs reading with known
chronology.
Evaluating the pros and cons of blinding to sequence is
not easy. Ideally, readers or image analysts would have
to take a set of images acquired sequentially in patients
and analyze them both ways, one blinded to sequence
and the other with known chronology in order to evaluate
the effect of blinding to sequence on estimates of rates of
change. Ideally, there also should be a gold standard deﬁ-
nition to which the reading or image analysis can be com-
pared, allowing an evaluation of tradeoffs between the
effect of blinding on rates of change vs accuracy of outcome
classiﬁcation. For such a comparison to be of relevance to
osteoarthritis, the images should have similar characteris-
tics to either X-rays or MRIs of the knees or other joints.
Speciﬁcally, they should be images in which planar mea-
surements are made on a 2D image or series of slices
with inferences made on where the edges of structures
are in three dimensions and whether, over time, there has
been a change in the position of these edges relative to
one another. That would deﬁne a change in joint space or
loss of cartilage.
We performed a MEDLINE search for articles published
1950 to current. Based on indexing of literature on blinding
to sequence, we used indexing terms ‘observer variation’ or
‘diagnostic error’, these exploded terms were cross refer-
enced with searches on the following content areas: spinal
fractures, angiography, coronary angiography, rheumatoid
arthritis (RA)/ra, duplex ultrasound carotid, osteoarthritis/ra
(the sufﬁx ‘ra’ refers to radiology studies). To ﬁnd additional
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found. After literature review, we found no studies evaluat-
ing reading blinded to sequence outside studies of spinal
fractures and RA. To our knowledge, this has not been
studied in osteoarthritis, and in vascular studies where
serial images are read with known chronology, the issue
has not arisen. Several studies, most of them of radio-
graphs in RA, addressed these exact concerns.
The one non-RA study examined serial spine radio-
graphs in patients with osteoporosis being followed for ver-
tebral fractures. While this study included a reference
reading to which the techniques were compared, it com-
pared a morphometric measure of vertebral fractures from
paired spine radiographs of known chronology to assess-
ment of non-paired, randomly presented, single spine ﬁlms
and not ﬁlms paired but blinded to sequence. Compared
with reference assessment, false positive rates for vertebral
fractures using single ﬁlms were 20% vs only 7% when
paired ﬁlms were read with known chronology. While not
directly examining the question of our focus, Ross and
colleagues stated, ‘We conclude that the assessments of
X-rays for vertebral fractures in clinical trials should not be
performed with the evaluator blinded to the sequence of
the x rays8’.Examples from studies of RA
Among studies evaluating progression of disease on
serial radiographs in patients with RA, designs have varied.
Most have compared the ﬁndings of paired readings either
blinded or unblinded to sequence with respect to reliability
and to how often progression is scored, but did not have
a gold standard reading to which the different strategies
could be compared.
Salafﬁ and Carotti9 read ﬁlms of the hands and wrists
from 100 patients with RA at baseline and 18 months. Films
were presented to each of two readers once with known
chronology and at another reading session paired and
blinded to sequence. The progression rates were higher
when ﬁlms were read with known chronology, but the
readers showed slightly better agreement on progression
when reading blinded to sequence.
In a study with a similar design10 three readers each
scored baseline and 12 month hand and foot radiographs
of 284 patients who had participated in a randomized trial.
When compared to readings that were paired but blinded
to sequence, readings done with known chronology showed
30e50% higher progression rates and 5e10% higher
standard deviations of those progression rates. The authors
expressed concern about the higher standard deviation of
progression rates and suggested that because the ‘preci-
sion’ of measurement was slightly greater with readings
that were paired and blinded to sequence, these might be
preferred. These authors did not take into account the
higher progression rates seen when ﬁlms were read with
known chronology. It is not clear whether this higher
standard deviation when ﬁlms were read with known
chronology meant greater variance of change or worse
reader reliability.
In a similarly designed study evaluating hand and feet
radiographs from 10 patients followed for a year and studied
twice, van der Heijde and colleagues2 had ﬁlms scored by
two experienced readers. They then conducted analyzes
looking at whether there were differences in progression
when examining ﬁlms presented paired with known chronol-
ogy vs blinded to sequence. They found a 50% higher rateof progression when ﬁlms were read with known chronol-
ogy. The standard deviation for progression was identical
for readings that were blinded to sequence vs read with
known chronology. The authors suggested that reading
with known chronology yielded a higher signal to noise ratio
for progression because of the higher rate of progression
seen using this approach.
Thus, all of the studies in RA have shown higher rates of
progression in patients where ﬁlms were read with known
chronology. The critical next question is whether the high
progression rates seen in reading these images with known
chronology are true cases of progression or represent false
positives. If the former, then studies should be read with
known chronology so as to increase the true signal detected
in serial ﬁlms. If the positives seen include many false
positives, then blinding to sequence is needed to enforce
a more conservative approach on readers. The only way
of addressing this issue is to carry out a study with a ‘gold
standard’ reading independent of the paired reading or to
have an independent assessment of true vs false positive.
More recently, Bruynesteyn and colleagues conducted
a study of hand and foot ﬁlms from RA patients who had
varying lengths of yearly follow ups. A group of experienced
readers11 reading the serial images with known chronology
independent of the tested readers providing the gold stan-
dard measurements of whether progression was present.
The ﬁlms were scored using two different scoring systems
widely used in RA, the Sharp/van der Heijde and Larsen
methods. There were two readers for each method, and
each of those readers read the paired ﬁlms both blinded
to sequence and, at a different time, with known chronology.
Thus, in this study, there was both a clearcut gold standard
reading and the ability to evaluate agreement between
readers when they read serial ﬁlms blinded to sequence
or with known chronology.
In this study, interreader reliability was much higher when
ﬁlms were read with known chronology. As a result, the
smallest detectable difference (SDD), was much larger for
radiographs read blinded to sequence than reliability based
on reading with known chronology. For example, when the
ﬁlms were read with known chronology, the SDD for the
progression score was 5.0 and the mean progression score
was 7.6, while for ﬁlms read blinded to sequence, the SDD
score was much higher (13.8), and the rate of progression
was much lower in this group (4.5). Thus, if ﬁlms were
read blinded to sequence, few subjects would have had
change beyond the SDD. Because of the poorer agreement
of readers when ﬁlms were read blinded to sequence and
the lower rates of change seen when using this approach,
sample size requirements for a dichotomous progression
outcome would be much greater if ﬁlms were read blinded
to sequence than if the ﬁlms were read with known
chronology.
With respect to agreement with the gold standard group
of readers, accuracy (based on the relationship between
sensitivity and speciﬁcity) was slightly greater when ﬁlms
were read with known chronology. This was true even
with the higher progression that was detected when ﬁlms
were so read. False positives were not created by this
approach. The authors concluded that knowing the chrono-
logical sequence leads to an increase in detecting clinically
relevant changes in patients without serious overestimation
of non-relevant differences and that ‘‘analysing a clinical
trial should be done preferably by reading ﬁlms in chrono-
logical order.’’
The authors suggested further that reading images
known to sequence would diminish sample size
Table I
Recommended approach to presenting serial images
Goal of study Suggested approach to
presenting images
Evaluating treatment efﬁcacy Known chronology*
Evaluating risk factors for disease Known chronology
Evaluating and comparing methods
for rates of incidence or progression
Blinded to sequence
*Exception if it is impossible to blind readers to treatment assign-
ment or effects of treatment (e.g., trial with no control group).
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issues of considerable concern in osteoarthritis where
structural changes are modest over time.
Thus the evidence suggests that in RA the higher pro-
gression rates noted when ﬁlms are presented with known
chronology generally reﬂect true progression and that mis-
classiﬁcation of progression does not occur at a higher
rate when ﬁlms are presented with known chronology.
The higher signal compared with roughly equivalent noise
translates into a better performance overall when ﬁlms are
presented with known chronology and that translates also
into likely fewer subjects needed in studies and a greater
likelihood of detecting treatment effects. While this may be
true for radiographic reading in RA, it has not been studied
in osteoarthritis and we can only speculate that it is of
relevance.
The primary rationale behind blinding to sequence is to
reduce reader bias toward ﬁnding change in the expected
direction. Ironically, in a clinical trial in which outcome as-
sessments are blinded to treatment assignment e a univer-
sally accepted standard e whatever bias there may be will
be equal across treatment groups. If readers can be blinded
to treatment assignment in a randomized trial, it is not
necessary to blind them also to the sequence of the ﬁlms
(see Table I). If they are unaware of treatment assignment,
their own biases cannot inﬂuence the trial results.
What then is the advantage of blinding to sequence and
when should it be done? If there is evidence of the
treatment on the image, then an outcome not based on
this image may be preferable to using the image to assess
outcome, as even presenting the image blinded to
sequence is unlikely to negate this source of bias.
Further, if the question of interest is not about treatment
efﬁcacy in a trial or in the case of epidemiologic studies,
about risk factors that increase the risk of progression but
rather the focus is on how often progression or some other
change occurs, then an argument can be made in favor of
blinding to sequence (Table I). If ﬁlms are read with known
chronology, a reader could have the inclination to over-read
progression (although in studies above that has not been
found).
On the other hand, one could also argue that accuracy is
more critical to determining rates of incidence and progres-
sion and if there is evidence that the risk of false positives is
actually greater with blinding to sequence, then even stud-
ies focusing of rates of change could beneﬁt from being
done with known sequence. Finally, if the trial has no
control group and one wants a conservative estimate of
whether a treatment has affected imaging outcomes, then
blinding to sequence may be preferable to reading with
known chronology.
For just about every other question in which the rates of
progression would be tied either to a treatment or a risk
factor, blinding to sequence may compromises the abilityof investigators to detect effects of interest. For risk factor
studies, blinding to sequence may impair the investigators’
ability to detect the effect of risk factors on disease
incidence or progression. For treatments, blinding to
sequence will make it more difﬁcult to detect small
treatment effects whose detection hinge on the ‘greater
accuracy’ of unblinded assessments e sensitivity and
power is increased because noise is reduced.
We conclude that, based on studies in RA, serial images
from trials and longitudinal studies of osteoarthritis patients
should usually be read with the images presented with
known chronology. This is true for both semi-quantitative
and quantitative evaluations that involve human judgments.
The ﬁndings from these RA studies need to be conﬁrmed
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